Indices of innovation: application of Data Envelopment Analysis and Malmquist Index Analysis in the assessment of R&D efficiency in R&D-critical sectors
Indices of innovation: application of Data Envelopment Analysis and Malmquist Index Analysis in the assessment of R&D efficiency in R&D-critical sectors
Maintaining or increasing R&D efficiency and productivity is a constant challenge for R&D-driven businesses, and companies in these sectors often explore strategies seen be effective in related sectors, for example the adoption of ‘open’ innovation by the pharmaceutical sector, based on its observed success in the information technology sector as reported by Chesbrough. The papers in this thesis address two gaps in the research literature: (1) the relative lack of established quantitative measures of the performance of open or other innovation strategies, and (2) the continuing challenge of assessing the effectiveness or otherwise of the OI paradigm outside its original high-tech industry focus. The pharmaceutical industry has been claimed as one of the pioneering industries where the principle of OI has been applied. In view of the limitations of prior research on R&D efficiency and OI in this industry, the question of whether OI is the best or only prescription for innovation in the pharmaceutical industry remains a strategic one. The first paper in the sequence identifies and explores systematic measures of innovation by investigating the adaptation and application of DEA as a candidate technique for analysing the R&D efficiency performance, using data on China’s high-tech industry sectors. The second paper explores how such ‘indices of innovation’ could be used to measure performance in terms of changes in R&D efficiency over time, in a case study of Procter and Gamble, a company widely recognised as an early adopter of OI. The third paper builds on the first two, using DEA and MI as ‘indices of innovation’ to measure whether adopting OI is leading to increased R&D efficiency in the pharmaceutical sector. Taken together, these papers explore (a) the feasibility if DEA and MI as new quantitative econometric ‘indices of innovation’, (b) their correlation with a known case of open innovation, and (c) to test the hypothesis that open innovation is increasing R&D efficiency in the pharmaceutical industry
Han, Chunjia
241d5aec-42dc-412e-bbc7-828b6c0638d3
June 2014
Han, Chunjia
241d5aec-42dc-412e-bbc7-828b6c0638d3
Thomas, Stephen
3ebf2346-25f1-4f19-b854-7a7da0cee9ca
Han, Chunjia
(2014)
Indices of innovation: application of Data Envelopment Analysis and Malmquist Index Analysis in the assessment of R&D efficiency in R&D-critical sectors.
University of Southampton, School of Management, Doctoral Thesis, 175pp.
Record type:
Thesis
(Doctoral)
Abstract
Maintaining or increasing R&D efficiency and productivity is a constant challenge for R&D-driven businesses, and companies in these sectors often explore strategies seen be effective in related sectors, for example the adoption of ‘open’ innovation by the pharmaceutical sector, based on its observed success in the information technology sector as reported by Chesbrough. The papers in this thesis address two gaps in the research literature: (1) the relative lack of established quantitative measures of the performance of open or other innovation strategies, and (2) the continuing challenge of assessing the effectiveness or otherwise of the OI paradigm outside its original high-tech industry focus. The pharmaceutical industry has been claimed as one of the pioneering industries where the principle of OI has been applied. In view of the limitations of prior research on R&D efficiency and OI in this industry, the question of whether OI is the best or only prescription for innovation in the pharmaceutical industry remains a strategic one. The first paper in the sequence identifies and explores systematic measures of innovation by investigating the adaptation and application of DEA as a candidate technique for analysing the R&D efficiency performance, using data on China’s high-tech industry sectors. The second paper explores how such ‘indices of innovation’ could be used to measure performance in terms of changes in R&D efficiency over time, in a case study of Procter and Gamble, a company widely recognised as an early adopter of OI. The third paper builds on the first two, using DEA and MI as ‘indices of innovation’ to measure whether adopting OI is leading to increased R&D efficiency in the pharmaceutical sector. Taken together, these papers explore (a) the feasibility if DEA and MI as new quantitative econometric ‘indices of innovation’, (b) their correlation with a known case of open innovation, and (c) to test the hypothesis that open innovation is increasing R&D efficiency in the pharmaceutical industry
Text
Han, Chunjia final thesis.pdf
- Other
More information
Published date: June 2014
Organisations:
University of Southampton, Southampton Business School
Identifiers
Local EPrints ID: 366276
URI: http://eprints.soton.ac.uk/id/eprint/366276
PURE UUID: 73a30632-a5ec-411a-874d-67b643dc4922
Catalogue record
Date deposited: 08 Jul 2014 12:05
Last modified: 14 Mar 2024 17:06
Export record
Contributors
Author:
Chunjia Han
Thesis advisor:
Stephen Thomas
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics